The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II, open label, single arm study on safety, tolerability and anti-tumour effiacy of orellanine treatment in patients with metastatic clear-cell or papillary renal cell carcinoma.
 
Sven Lundstam
Consulting or Advisory Role - IPSEN; MSD
 
Boerje Haraldsson
Employment - Oncorena
Leadership - Oncorena; UGLK Science
Stock and Other Ownership Interests - Novartis; Oncorena; UGLK Science
Consulting or Advisory Role - Gesynta
Patents, Royalties, Other Intellectual Property - Oncorena
 
Jenny Nystrom
Stock and Other Ownership Interests - Oncorena
Consulting or Advisory Role - ANI Pharmaceuticals; AstraZeneca
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Oncorena
 
Jeffrey Yachnin
No Relationships to Disclose